London - University College London

UCL ECMC

University College London (UCL) is committed to performing world-class clinical cancer research to develop new cancer therapies and undertake early phase clinical trials that are fully informed by modern molecular and imaging technologies. There is particular expertise and dedicated facilities for trials of antibody-targeted, radiation, photodynamic and vascular therapies and biomedical informatics.

Clinical Focus Area

  • Medical Oncology
  • Radiotherapy
  • Antibody targeted therapy
  • Small molecule drug development
  • Biomarkers
  • Immunotherapy
  • Cellular therapy
  • Imaging
  • Gene therapy
 

Scientific Focus Area

  • Antibody engineering
  • Molecular diagnostics
  • Circulating tumour cells
  • DNA interactive agents
  • Epigenetics
  • T cell responses
  • DNA Ploidy
  • Pharmacokinetics & Pharmacodynamics
  • Drug Discovery
 

Disease Focus Area

Bone Brain Colorectal Hodgkin's Disease
Leukaemia Liver Lung Non-Hodgkin's Lymphoma
Ovarian Pancreatic Sarcoma Relevant to all Types of Cancer
 

Goals

Goals

For further information on the goals and objectives of UCL ECMC go to:

More about Goals

 

Skills

Skills

UCL ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

 

Facilities

Facilities

UCL ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities